Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

(2021) Julian Breidenbach et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication

(2021) Shin-ichiro Hattori et al.   Nature Communications

An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19

(2021) Dafydd R. Owen et al.   SCIENCE

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

(2020) Timothy P. Sheahan et al.   Nature Communications

The Architecture of SARS-CoV-2 Transcriptome

(2020) Dongwan Kim et al.   CELL

Antiviral activity of traditional Chinese medicinal plants Dryopteris crassirhizoma and Morus alba against dengue virus

(2020) Maqsood MARYAM et al.   Journal of Integrative Agriculture

Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection

(2020) Dan Gao et al.   Frontiers in Pharmacology

Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems

(2020) Goki Suda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

(2020) Li Runfeng et al.   PHARMACOLOGICAL RESEARCH

Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis

(2020) Arthur Yin Fan et al.   Journal of Integrative Medicine-JIM

SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging

(2020) Wioletta Rut et al.   Nature Chemical Biology

Characteristics of SARS-CoV-2 and COVID-19

(2020) Ben Hu et al.   NATURE REVIEWS MICROBIOLOGY

Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines

(2020) Lei Wu et al.   PHARMACOLOGICAL RESEARCH

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

(2020) Lifeng Fu et al.   Nature Communications

Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections

(2020) Young-Hee Jin et al.   PHYTOMEDICINE

Protease Inhibitors for the Treatment of HIV/AIDS: Recent Advances and Future Challenges

(2019) Chandrashekhar Voshavar   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Anti-Influenza Virus (H5N1) Activity Screening on the Phloroglucinols from Rhizomes of Dryopteris crassirhizoma

(2017) Juan Wang et al.   MOLECULES

In vivo anthelmintic effect of flavonol rhamnosides from Dryopteris crassirhizoma against Dactylogyrus intermedius in goldfish (Carassius auratus)

(2013) Bing Jiang et al.   PARASITOLOGY RESEARCH

Inhibition of porcine reproductive and respiratory syndrome virus replication by flavaspidic acid AB

(2012) Qian Yang et al.   ANTIVIRAL RESEARCH

ERK1- and TBK1-targeted anti-inflammatory activity of an ethanol extract of Dryopteris crassirhizoma

(2012) Yanyan Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Influences of Dryopteris crassirhizoma Extract on the Viability, Growth and Virulence Properties of Streptococcus mutans

(2012) Suk-Ho Ban et al.   MOLECULES

Two New Triterpenes from the Rhizome of Dryopteris crassirhizoma, and Inhibitory Activities of Its Constituents on Human Immunodeficiency Virus-1 Protease

(2008) Ji Suk Lee et al.   CHEMICAL & PHARMACEUTICAL BULLETIN